Article Details

GSK and CureVac to develop next generation mRNA COVID-19 vaccines

Retrieved on: 2021-02-03 12:44:39

Tags for this article:

Click the tags to see associated articles and topics

GSK and CureVac to develop next generation mRNA COVID-19 vaccines. View article details on hiswai:

Excerpt

GSK will also support the manufacture of up to 100 million doses of CureVac's first generation COVID-19 vaccine candidate CVnCoV in 2021. Through ...

Article found on: www.gsk.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo